Skip to the story
All stories

Bayer to build $2.2bn Ohio plant creating 600 jobs

The pharmaceutical company announced plans for a new manufacturing site in New Albany, Ohio.

AI-assisted coverage comparison, editor-supervised · How this was made

Published
Bayer to build $2.2bn Ohio plant creating 600 jobs

What this story says

  • Bayer announced a $2.2 billion investment in a new pharmaceutical manufacturing site in New Albany, Ohio.
  • The facility is projected to create around 600 high-value jobs and approximately 1,500 construction jobs.
  • The first part of the plant is scheduled to begin operations in 2031, with a second module planned for 2034.
  • This investment is part of Bayer's strategy to expand its pharmaceutical business and patient access in the US.

Who covered it

Left 0%(0)Centre 57%(4)Right 43%(3)

Percentages are shares of the 7 outlets carrying a published leaning rating. 6 of the 13 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

60/100

Craft

60/100

Hype

20/100

13 sources · methodology

Thin on the left so far

None of the 7 outlets with a published leaning rating that ran this story are rated left.

This story is still being watched, so it is a count and not yet a finding. Coverage keeps arriving for hours after an event, and a side that has published nothing this morning may publish by tonight. If it is still true when we stop checking, we will say so plainly.

Bayer plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. The company announced the project on 2 October 2026, stating it is part of a long-term growth strategy and commitment to innovation and patient access in the US. The new facility is expected to create approximately 600 high-value jobs and around 1,500 construction jobs. The first module of the site, dedicated to drug substance manufacturing, is anticipated to become operational in 2031, with a second module for drug product manufacturing planned for 2034.

Coverage disagreements

One report stated that the new facility would be built in the New Albany International Business Park, while another mentioned it would be located in the New Albany International Business Park, part of the Columbus Region. The Manila Times reported that the project will pursue a Job Creation Tax Credit from the Ohio Department of Development and may seek JobsOhio assistance, with details to be made public after a final agreement. Other reports did not mention these specific details regarding tax credits or assistance.

What the coverage left out

None of the right-rated reports mention the Ohio Life Science Training Center, which Bayer will draw on to train workers. The centre-rated reports also omit details about the specific types of drugs to be manufactured at the facility, such as oncology, cardiovascular, and renal care products, as well as the flexible, modular design of the campus.

Still developing. We have re-checked which outlets are covering this 2 times, most recently on 2 Oct 2026, 20:30, and will add the sides that appear.

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

0 rated outlets

No outlet rated left has run this story so far. We are still checking, and will say plainly if that does not change.

Centre

4 rated outlets

  • The centre-rated reports led on Bayer's announcement of a $2.2 billion investment in a new US pharmaceutical manufacturing site. They noted the creation of approximately 600 high-value jobs and roughly 1,500 construction jobs. Both reports mentioned that the first module of the facility is expected to be operational in 2031, with a second module planned for 2034. The investment is described as part of Bayer's strategy to boost its US revenue and business.

Right

3 rated outlets

  • The right-rated reports highlighted Bayer's $2.2 billion investment in a new manufacturing site in Ohio. They noted the creation of around 600 high-value jobs and approximately 1,500 construction jobs. One report mentioned that cancer, heart, and kidney drugs would be produced there, strengthening Bayer's US business. Another report linked the investment to US President Donald Trump's efforts to combat high drug prices, suggesting pharmaceutical companies are building factories in the US to appease him. The Manila Times, which provided a full report, included statements from Ohio Governor Mike DeWine, Bayer CEO Bill Anderson, and Senator Bernie Moreno, and detailed the workforce readiness and infrastructure supporting the project.

Questions about this coverage

How did the left and right cover Bayer to build $2.2bn Ohio plant creating 600 jobs?
Of the 7 outlets on this story carrying a published leaning rating, 0% are rated left, 57% are rated centre, 43% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 13. The sections above set out what each side emphasised, in its own terms.
Is Bayer to build $2.2bn Ohio plant creating 600 jobs left or right?
Too few of the outlets on this story carry a published leaning rating to say. 7 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.
Is the coverage of Bayer to build $2.2bn Ohio plant creating 600 jobs biased?
Bayer to build $2.2bn Ohio plant creating 600 jobs is one event reported by 13 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which side is not reporting Bayer to build $2.2bn Ohio plant creating 600 jobs?
When we first saw this story, outlets rated left had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.
Which outlets covered Bayer to build $2.2bn Ohio plant creating 600 jobs?
13 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
How much is Bayer investing in the new Ohio facility?
Bayer is investing $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio. This investment is part of the company's long-term strategy to grow its pharmaceutical business and enhance patient access in the United States.
How many jobs will the new Bayer facility create?
The new Bayer facility is expected to create approximately 600 high-value jobs and around 1,500 construction jobs. These roles will support the manufacturing and operation of the pharmaceutical site.
When will the new Bayer plant become operational?
The first module of the Bayer manufacturing site, focused on drug substance production, is scheduled to become operational in 2031. A second module for drug product manufacturing is planned to follow in 2034.

Read it at the source

13 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

0

No outlet in this group ran the story.

Centre

4

Right

3

Not rated

6

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

Bayer Ohio plant investment | MediaBias News